Mira Pharmaceuticals (MIRA) Other Working Capital Changes (2022 - 2025)

Mira Pharmaceuticals has disclosed Other Working Capital Changes across 4 years of filings, most recently posting -$33789.0 for Q4 2025.

• Other Working Capital Changes for Q4 2025 came in at -$33789.0, down 6.11% year-over-year; the trailing twelve-month figure through Dec 2025 was -$17957.0 (up 90.5% YoY), and the FY2025 annual result was $429999.0, up 59.92% from the prior year.
• Other Working Capital Changes came in at -$33789.0 for Q4 2025 at Mira Pharmaceuticals, down from $369999.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $369999.0 in Q3 2025 to a low of -$76714.0 in Q2 2024.
• The 4-year median for Other Working Capital Changes is -$17507.0 (2023), against an average of $33900.7.
• Across the five-year window, Other Working Capital Changes soared 7547.57% in 2023 and tumbled 338.19% in 2024, its largest moves.
• Mira Pharmaceuticals' Other Working Capital Changes stood at $2096.0 in 2022, then jumped by 1855.39% to $40985.0 in 2023, then slumped by 177.69% to -$31842.0 in 2024, then slipped by 6.11% to -$33789.0 in 2025.
• The last three Other Working Capital Changes figures came in at -$33789.0 (Q4 2025), $369999.0 (Q3 2025), and -$56210.0 (Q2 2025), per Business Quant data.